GLP-1 RAs as an add-on showed a reduction in BMI compared to controls (mean difference 1.38 kg/m, low certainty evidence)
The Phase 2 data showed that 92% of participants in the 4 mg group achieved at least 5% weight loss, 75% achieved at least 10%, and 60% achieved at least 15% at 48 weeks
A randomized, double-blind, placebo-controlled, phase 3 study comparing the efficacy and safety of tirzepatide versus placebo in patients with heart failure with preserved ejection fraction and obesity (SUMMIT)
Cellular studies, including cytotoxicity studies, and the DNA damage test, demonstrated the essential roles of AP probe-net in their cytotoxicity
Just started using it but im already down 5 pounds Already 6 lbs down
When Can You Restart Wegovy After Surgery